Clinical Research Directory
Browse clinical research sites, groups, and studies.
3 clinical studies listed.
Filters:
Tundra lists 3 Polyendocrine Metabolic Ovarian Syndrome clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07747259
Comparison of Core Stability, Body Awareness, Pelvic Health, Sleep, and Quality of Life in Physically Active Women With and Without Polyendocrine Metabolic Ovarian Syndrome
Aim of the study was to compare physically active women with and without Polyendocrine Metabolic Ovarian Syndrome (PMOS) in terms of core stability, body awareness, pelvic health, sleep, and quality of life, and to reveal the possible effects of the presence of PMOS on these parameters despite physical activity.
Gender: FEMALE
Ages: 18 Years - 40 Years
Updated: 2026-10-01
NCT07822360
Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital
The aim of this study is to determine the prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among female patients diagnosed with acne vulgaris in Sohag university hospital
Gender: FEMALE
Ages: 15 Years - 49 Years
Updated: 2026-09-16
NCT07750899
The Effect of Standardized Withania Somnifera Extract on Endocrine, Metabolic, and Psychometric Parameters, in Women With Polyendocrine Metabolic Ovarian Syndrome
The objective of this study is to ascertain the impact of a standardized Withania somnifera extract on endocrine, metabolic, and psychometric parameters in women diagnosed with polyendocrine metabolic ovarian syndrome. The assessment will encompass a range of parameters to determine the severity of depression, stress levels, the quality of sleep, blood pressure, body mass index, and body composition. Additionally, biochemical, metabolic, and endocrine blood parameters in serum will be analysed. The trial's findings may yield a safe and easy-to-use method of adjunctive treatment that could complement therapy in patients with polycystic ovary syndrome.
Gender: FEMALE
Ages: 18 Years - 45 Years
Updated: 2026-08-06